Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 week ago Contract award

Polska - Różne produkty lecznicze - „Dostawa leków onkologicznych w programie lekowym i w chemioterapii na potrzeby COZL.” (znak postępowania: COZL/DZP/AW/3411/PN-190/25)

Awarded Poland Lubelskie Medical equipment & pharmaceuticals

Buyer Centrum Onkologii Ziemi Lubelskiej im. Św. Jana z Dukli

€1.9M awarded value · €1,907,203

Key facts

Awarded
Procedure
Open procedure
  1. Awarded
  2. Published
  3. Contract ends, estimated March 2027
View the official notice Watch this tender

This contract runs about 12 months, so it is back on the market around March 2027. Log in

Awarded to

Urtica Sp. z o.o.

Awarded value
€1,907,203
Award date
Bids received
13 over 7 lots
Record with this buyer
5 contracts from this buyer in the register, €35.0M in total
Back on the market
Mar 2027 How we know

When this contract comes back

estimated from the stated duration

This contract runs about 12 months, so it is back on the market around March 2027.

Every contract expiring, on the radar

Description

2. „Dostawa leków onkologicznych w programie lekowym i w chemioterapii na potrzeby COZL.” Zamówienie zostało podzielone na 61 części: Część 1 - Vandetanib Część 2 - Romosozumab Część 3 - Carboplatyna Część 4 - Methotrexate Część 5 - Siltuksymab Część 6 - Acidum zoledronicum Część 7 - Dezatynib Część 8 - Filgrastin Część 9 - Melphalanum Część 10 - Pegfilgrastim Część 11 - Tacrolimus Część 12 - Chlorambucil Część 13 - Temsirolimusum Część 14 - Crizotinibum Część 15 - Melphalan Część 16 - Trabectydyna Część 17 - Methotrexatum Część 18 - Avelumab Część 19 - Ponatynibum Część 20 - Mosunetuzumab Część 21 - Isatuximab Część 22 - Tretinoin Część 23 - Ravulizumab Część 24 - Nivolumab + Relatlimab Część 25 - Mitoxantrone Część 26 - Epirubicin Część 27 - Bicalutamide I Część 28 - Cabazytaxel Część 29 - Doxorubicyna liposomalna Część 30 - Denosumab Część 31 - Mitomycin Część 32 - Pertuzumab Część 33 - Rasburicasum Część 34 - Obinutuzumab Część 35 - Trastuzumab Emtansine Część 36 - Venetoclaxum Część 37 - Ibrutinib Część 38 - Cyclophosphamide Część 39 - Mesnum Część 40 - Ifosfamide Część 41 - Panitumumab Część 42 - Pegaspargase Część 43 - Niraparyb Część 44 - Capecytabina Część 45 - Fulvestrantum Część 46 - Everolimus Część 47 - Paclitaxelum albuminatum Część 48 - Pemetrexet Część 49 - Oxaliplatyna Część 50 - Rybocyclib Część 51 - Trametinib Część 52 - Octreotide Część 53 - Nilotynib Część 54 - Sunitynib Część 55 - Vinorelbina Część 56 - Bleomycin Część 57 - Dacarbazine Część 58 - Acidum Levofolinicum Część 59 - Fluorouracil Część 60 - Inotuzumabum ozogamicini Część 61 - Bicalutamide II „Dostawa leków onkologicznych w programie lekowym i w chemioterapii na potrzeby COZL.” Część 5 - Siltuksymab; „Dostawa leków onkologicznych w programie lekowym i w chemioterapii na potrzeby COZL.” Część 11 - Tacrolimus; „Dostawa leków onkologicznych w programie lekowym i w chemioterapii na potrzeby COZL.” Część 18 - Avelumab; „Dostawa leków onkologicznych w programie lekowym i w chemioterapii na potrzeby COZL.” Część 24 - Nivolumab + Relatlimab; „Dostawa leków onkologicznych w programie lekowym i w chemioterapii na potrzeby COZL.” Część 51 - Trametinib; „Dostawa leków onkologicznych w programie lekowym i w chemioterapii na potrzeby COZL.” Część 52 - Octreotide; „Dostawa leków onkologicznych w programie lekowym i w chemioterapii na potrzeby COZL.” Część 55 - Vinorelbina

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago

What this buyer has paid before

Based on 124 comparable contracts this buyer awarded in this sector over the last 4 years.

This award
€1.9M
Median award
€289,985
Middle half of past awards
€114,494 to €626,834

The award is larger than three in four past awards.

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Centrum Onkologii Ziemi Lubelskiej im. Św. Jana z Dukli

Poland

notices in the register
407
awards
203
awarded in total
€153.2M

Who wins its contracts

Many suppliers
different companies won its awards
159
of the awards went to the three most frequent winners
7%
of its calls state an estimated value
0%

Based on 190 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.5
of those lots received a single tender
72%
of the awards went to companies based in another country
4%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.

Awards most often to

  1. URTICA Sp. z o.o. 5 awards €35.0M
  2. STORIO Spółką z ograniczoną odpowiedzialnością spółką komandytową 5 awards €1.7M
  3. Asseco Poland S.A. 4 awards €1.8M

12 open tenders right now

Market context

open now in Medical equipment & pharmaceuticals
8,281
median open notice
€306,699

Who wins in this market

Many suppliers

Poland · Medical equipment & pharmaceuticals

different companies won awards here
13,373
of the awards went to the three most frequent winners
4%
buyers awarded contracts here
1,462

Based on 22,919 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.8
of those lots received a single tender
63%
of the awards went to companies based in another country
2%
of the tenders came from another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Award date
    Was: March 4, 2026
    Now: March 4, 2026
    Scope and criteria
    The description was expanded. Re-read it before you bid.
    Award value
    Was: €1,916,772
    Now: €1,907,203

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Open now

Awarded before

Never miss a tender like this

993 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Various medicinal products: an email when new tenders arrive under it, no account needed.

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language